Contact us
Home
About Us
History
Management Team
Board of Directors
Scientific Advisory Board
Investors
Technology
About Antibodies
Our Technologies
Pipeline
Disease Areas
Business Strategy
Applied Research
Clinical Development
Partnering
Communications
Press Releases
Company Presentations
Scientific Publications
Event Calendar
Career
Latest News
Genentech initiates First-in-Human study with NovImmune’s anti-IL17 antibody 
 (read ) 
| Print |
 
HomePrivacy & TermsContact usSite map
© NovImmune 2008
π